Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2000
12/28/2000WO2000078809A1 Axor16, a g protein coupled receptor
12/28/2000WO2000078806A1 Mage-a1 peptides presented by hla class ii molecules
12/28/2000WO2000078805A1 Peptide having preptin functionality
12/28/2000WO2000078804A1 Immune response regulatory proteins
12/28/2000WO2000078802A2 Secreted polypeptides and corresponding polynucleotides
12/28/2000WO2000078799A2 Mlo-genes controlling diseases
12/28/2000WO2000078781A1 Detection of giardia
12/28/2000WO2000078455A1 Devices and methods for the performance of miniaturized in vitro amplification assays
12/28/2000WO2000078444A2 Method and device for carrying out biochemical reactions with a high throughput
12/28/2000WO2000078361A2 Methods of imaging and targeting tumor vasculature
12/28/2000WO2000078346A1 Novel anti-allergic agents
12/28/2000WO2000078341A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000WO2000078334A1 Chimeric chemokine-antigen polypeptides and uses therefor
12/28/2000WO2000078327A2 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication
12/28/2000WO2000078266A2 Interferon tau mutants and methods for making them
12/28/2000WO2000078119A2 Cardiomyocytes with enhanced proliferative potential
12/28/2000WO2000058460A3 Casb619 involved in colon cancers
12/28/2000WO2000056905A3 Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
12/28/2000WO2000056903A3 IMPROVED METHODS FOR PRODUCING PROTEINS IN TRANSFORMED $i(PICHIA)
12/28/2000WO2000056872A3 High-throughput gene cloning and phenotypic screening
12/28/2000WO2000056444A3 Spatially directed interaction on a solid surface
12/28/2000WO2000055339A3 Method and device for immobilization of polarizable cells of higher plants by the use of a high frequency ac-field
12/28/2000WO2000055336A3 Ve protein and nucleic acid sequences, compositions, and methods for plant pathogen resistance
12/28/2000WO2000053767A3 Nucleic acid respiratory syncytial virus vaccines
12/28/2000WO2000053735A3 Methods for identifying modulators of synaptic plasticity and cell motility
12/28/2000WO2000053729A3 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine
12/28/2000WO2000053724A3 Compositions and methods for the modification of gene transcription
12/28/2000WO2000052181A3 Gcn4-derived expression of heterologous coding sequences and different uses thereof
12/28/2000WO2000052133A3 Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same
12/28/2000WO2000050594A3 Mammalian alpha-helical protein, zsig83
12/28/2000WO2000050074A3 Neisserial vaccine compositions and methods
12/28/2000WO2000050051A3 Reovirus for the treatment of cellular proliferative disorders
12/28/2000WO2000049162A3 Compositions and methods for non-targeted activation of endogenous genes
12/28/2000WO2000049157A3 Compositions and methods for altering sulfur content in plants
12/28/2000WO2000048625A3 Inhibitors for use in hemostasis and immune function
12/28/2000WO2000046355B1 Telomerase reverse transcriptase transcriptional regulatory sequences
12/28/2000WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes
12/28/2000WO2000045851A3 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
12/28/2000WO2000044898A3 Novel agouti and agouti-related peptide analogs
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000040593A3 Target molecule attachment to surfaces
12/28/2000WO2000037640A3 Compositions and methods for the treatment of tumor
12/28/2000WO2000035465A3 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
12/28/2000WO2000034474A3 Growth factor homolog zvegf3
12/28/2000WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
12/28/2000WO2000030667A3 Compositions and methods using lactadherin or variants thereof
12/28/2000WO2000017369B1 Alzheimer's disease secretase
12/28/2000DE19957116A1 Synthesis of polymers, especially nucleic acids, useful e.g. for therapy or diagnosis, by parallel synthesis of many oligomers on a carrier then sequential release and assembly
12/28/2000DE19929569A1 Composition for treating malignant disease, comprising E1A-defective adenovirus that can replicate in presence of YB-1 protein
12/28/2000DE19929365A1 New genes from Corynebacterium glutamicum, useful for modifying cells for production of primary or secondary metabolites, e.g. amino or fatty acids
12/28/2000DE19929364A1 New Corynebacterium glutamicum dihydroorotate dehydrogenase polypeptide and corresponding DNA useful for creating pyrimidine-producing organisms
12/28/2000DE19929363A1 New Corynebacterium glutamicum GTP cyclohydrolase I, dihydropteroate synthase, dihydroneopterin aldolase and 2-amino-4-hydroxy-6-hydroxymethyl-dihydropteridine pyrophosphokinase polypeptides
12/28/2000DE19928342A1 New vector for tissue-specific expression, useful for treating tumors, contains gene for e.g. a cytotoxin under control of tissue-specific promoter and enhancer
12/28/2000CA2783140A1 Srsv detection kit
12/28/2000CA2397494A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 1 promoter and terminator
12/28/2000CA2382425A1 Interferon tau mutants and methods for making them
12/28/2000CA2378687A1 Nucleotide sequences of moraxella catarrhalis genome
12/28/2000CA2377707A1 Improved primers and methods for the detection and discrimination of nucleic acids
12/28/2000CA2377524A1 Novel anti-allergic agents
12/28/2000CA2377270A1 Cardiomyocytes with enhanced proliferative potential
12/28/2000CA2377263A1 Polynucleotides and polypeptides encoded thereby
12/28/2000CA2377188A1 Methods of imaging and targeting tumor vasculature
12/28/2000CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000CA2375911A1 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands
12/28/2000CA2375905A1 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
12/28/2000CA2375880A1 A vector for the expression of two foreign genes
12/28/2000CA2375869A1 Regulation system of expression using nuclear ppar receptors
12/28/2000CA2375831A1 Plant multi-gene expression constructs
12/28/2000CA2375828A1 Sunflower anti-pathogenic proteins and genes and their uses
12/28/2000CA2375821A1 Novel vectors for improving cloning and expression in low copy number plasmids
12/28/2000CA2375817A1 Regulated expression of cloned genes using a cascade genetic circuit
12/28/2000CA2375805A1 Overexpression in yeast and plants of a gene encoding glycerol 3-phosphate acyltransferase
12/28/2000CA2375798A1 Capillary electrophoresis method for screening for affinity ligands using a detectable competitive ligand
12/28/2000CA2375791A1 Avirulent xanthomonas-campestris strains producing xanthan
12/28/2000CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci
12/28/2000CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1
12/28/2000CA2375508A1 Methods and products for manipulating uncoupling protein expression
12/28/2000CA2375502A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof
12/28/2000CA2375498A1 Epithelial cell growth inhibitors
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375490A1 Chimeric oca-b transcription factors
12/28/2000CA2375484A1 In vivo insect model system for type-2 diabetes
12/28/2000CA2375482A1 Rapid growing microorganisms for biotechnology applications
12/28/2000CA2375480A1 Head trauma induced cytoplasmatic calcium binding protein
12/28/2000CA2375477A1 Novel calpains and their use
12/28/2000CA2375475A1 Serin proteinase inhibitors
12/28/2000CA2375414A1 Human transcriptional regulator proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375236A1 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
12/28/2000CA2375207A1 Peptide having preptin functionality
12/28/2000CA2373910A1 Process for the enzymatic modification of pectin
12/28/2000CA2372703A1 Scorpion toxins
12/28/2000CA2372701A1 Scorpion toxins
12/28/2000CA2370414A1 Rice sucrose synthase promoter
12/28/2000CA2340329A1 Method of increasing the resistance of cultivated plants to phytopathogenic fungi and bacteria by methods of molecular genetics
12/28/2000CA2340319A1 Method for producing plants with increased flavonoid and phenolic compound content
12/28/2000CA2340279A1 Method for increasing the resistance of cultivated plants to chemical stress
12/27/2000EP1063298A2 Transgenic Animal Model for Alzheimer Disease
12/27/2000EP1063297A1 Farnesyl pyrophosphate synthase (FPS) derived from seedlings of sunflower (Helianthus annus)
12/27/2000EP1063296A1 Nucleic acid enzyme showing allosteric rna-cleaving activity on target rna
1 ... 3134 3135 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 ... 4023